Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF NORTH CAROLINA HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.unc.edu/interactive-tour/unc-hospitals/

Clinical Trials

Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: lapatinib ditosylate

First Posted Date: 2005-10-30

Last Posted Date: 2017-06-28

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 29

Registration Number: NCT00246753

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
🇺🇸
Rex Cancer Center at Rex Hospital, Raleigh, North Carolina, United States

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

Phase 1

Completed

Conditions: Leukemia
Breast Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Ovarian Cancer

Interventions: Drug: PS-341
Drug: Doxil
Drug: Velcade

First Posted Date: 2005-10-12

Last Posted Date: 2012-05-18

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 107

Registration Number: NCT00237627

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery

Phase 2

Completed

Conditions: Breast Cancer

First Posted Date: 2005-10-06

Last Posted Date: 2012-03-07

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 15

Registration Number: NCT00233974

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Biological: cetuximab
Drug: carboplatin

First Posted Date: 2005-10-04

Last Posted Date: 2017-06-28

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 112

Registration Number: NCT00232505

Locations: 🇺🇸
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, United States
🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, D.C., District of Columbia, United States

and more 11 locations

Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme

Phase 1

Terminated

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: erlotinib hydrochloride

First Posted Date: 2005-09-27

Last Posted Date: 2012-03-06

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 10

Registration Number: NCT00227032

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: docetaxel
Drug: leuprolide acetate
Radiation: radiation therapy

First Posted Date: 2005-09-23

Last Posted Date: 2017-06-01

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 23

Registration Number: NCT00225420

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸
Rex Cancer Center at Rex Hospital, Raleigh, North Carolina, United States

Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

First Posted Date: 2005-09-16

Last Posted Date: 2024-10-01

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 89

Registration Number: NCT00182728

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women

Phase 1

Completed

Conditions: Breast Cancer
Endometrial Cancer

First Posted Date: 2004-12-09

Last Posted Date: 2013-05-21

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 30

Registration Number: NCT00099008

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Biological: therapeutic autologous dendritic cells
Biological: trastuzumab
Drug: vinorelbine ditartrate

First Posted Date: 2004-08-05

Last Posted Date: 2017-06-20

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 56

Registration Number: NCT00088985

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus

Phase 1

Completed

Conditions: Esophageal Cancer

First Posted Date: 2004-07-30

Last Posted Date: 2012-05-24

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 26

Registration Number: NCT00002984

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy